Oncology & Cancer

Cancer: A new killer lymphocyte enters the ring

Treatments for beating tumors are mainly based on CD8 T lymphocytes, which specialize in detecting and eliminating intracellular infections and in killing cancer cells. A large proportion of patients, however, do not respond ...

Cardiology

Researchers find new biomarker for active sarcoidosis

Low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis—an inflammatory disease that attacks multiple organs, particularly ...

Diseases, Conditions, Syndromes

Genetics may play role in determining immunity to COVID-19

Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting concerns about the prospects of long-lasting immunity and efficacy of COVID-19 ...

Oncology & Cancer

CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen receptor (CAR) T cell therapy Kymriah, researchers ...

Diseases, Conditions, Syndromes

Privileged white U.S. citizens have better health outcomes

(HealthDay)—Privileged White U.S. citizens have better health outcomes than average U.S. citizens for several health outcomes, but health outcomes are not always better than those in other developed countries, according ...

Oncology & Cancer

Study opens the door to new treatments against colon cancer

A research group of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) and the Hospital Arnau de Vilanova has released a pioneering study, which for the first time links the development ...

page 11 from 40